VK2735
VK2735 is a dual agonist of the GLP-1 receptor and GIP receptor, with a similar mechanism of action as tirzepatide, which acts on the same receptors.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
VK2735 is a dual agonist of the GLP-1 receptor and GIP receptor, with a similar mechanism of action as tirzepatide, which acts on the same receptors. Both injectable and oral forms are being developed by Viking Therapeutics.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368314401 under CC BY-SA 4.0; modifications have been made.